Press Releases OncoCyte Corporation

Equities

Delayed Nasdaq Other stock markets 16:04:18 01/05/2024 BST			5-day change	1st Jan Change
2.5 ^USD	+0.40%		+1.63%	0.00%

04-25	OncoCyte Corporation announced that it has received $15.8 million in funding	CI
04-16	Broadwood Capital, Inc. Engages with OncoCyte Corporation	CI

ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS	04-15	AQ
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules	04-15	AQ
Oncocyte Reports Full Year 2023 Financial Results	04-12	AQ
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules	04-12	AQ
Oncocyte : and Bio-Rad Partner on Global Launch of Transplant Assay - Form 8-K	04-11	PU
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay	04-11	AQ
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results	04-09	AQ
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico	01-16	AQ
Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays	12-06	AQ
OncoCyte: Q3 Earnings Snapshot	11-09	AQ
Oncocyte Reports Third Quarter 2023 Financial Results	11-09	AQ
Oncocyte to Announce Third Quarter 2023 Financial Results	11-03	AQ
OncoCyte : Change in Certifying Accountants - Form 8-K	05/10/23	PU
Oncocyte : Investor Presentation	03/10/23	PU
ONCOCYTE'S VITAGRAFTTM KIDNEY IDENTIFIES TRANSPLANT REJECTION 10 MONTHS EARLIER	19/09/23	AQ
Oncocyte : Investor Presentation	21/08/23	PU
OncoCyte: Q2 Earnings Snapshot	10/08/23	AQ
VitaGraft Kidney Expands Utility in Recurrent Primary Disease Patients	25/07/23	AQ
Oncocyte Announces 1-For-20 Reverse Stock Split	24/07/23	AQ
Oncocyte Begins Manufacturing Transplant Blood Test	27/06/23	AQ

No results for this search